Itau Unibanco Holding S.A.’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,508
Closed -$15.9K 413
2024
Q2
$15.9K Buy
+1,508
New +$16.5K ﹤0.01% 244
2024
Q1
Sell
-2,393
Closed -$26.9K 312
2023
Q4
$26.9K Sell
2,393
-416
-15% -$4.05K ﹤0.01% 251
2023
Q3
$32.8K Buy
2,809
+686
+32% +$7.75K ﹤0.01% 323
2023
Q2
$21.4K Sell
2,123
-882
-29% -$7.89K ﹤0.01% 404
2023
Q1
$22.2K Sell
3,005
-17
-0.6% -$140 ﹤0.01% 391
2022
Q4
$24.1K Sell
3,022
-743
-20% -$4.13K ﹤0.01% 373
2022
Q3
$12K Buy
+3,765
New +$14.6K ﹤0.01% 485

Other funds holding ROIV

Itau Unibanco Holding S.A.'s ROIV Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Roivant Sciences (ROIV) in Q3 2024, closing a stake of 1,508 shares — an estimated $15.9K sold.

Itau Unibanco Holding S.A. first reported a position in ROIV in Q3 2022 and held it in 7 quarters. The position peaked at $32.8K in Q3 2023. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Roivant Sciences position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,508 Roivant Sciences shares in Q3 2024, an estimated $15.9K.
  • Itau Unibanco Holding S.A. first reported a position in Roivant Sciences in Q3 2022 and held it in 7 quarters.
  • Itau Unibanco Holding S.A.'s Roivant Sciences position peaked at $32.8K in Q3 2023.
  • 293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.